Glucose Regulates the Expression of the Farnesoid X Receptor in Liver

Diabetes

Volumn 53, Issue 4, 2004, Pages 890-898

  Duran Sandoval, Daniel ^a   Mautino, Gisèle ^a   Martin, Geneviève ^b   Percevault, Fréderic ^a   Barbier, Olivier ^a   Fruchart, Jean Charles ^a   Kuipers, Folkert ^c   Staels, Bart ^a,d  

^a UNIV LILLE   (France)

^b Parc Eurasante Lille Metropole   (France)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; BILE ACID; FARNESOID X RECEPTOR; GLUCOSE; LIGAND; PENTOSE PHOSPHATE; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; XYLITOL; XYLULOSE; XYLULOSE 5 PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOLIPOPROTEIN C III GENE; ARTICLE; BILE ACID METABOLISM; CONTROLLED STUDY; DIABETES MELLITUS; DNA BINDING; DOSE TIME EFFECT RELATION; FARNESOID X RECEPTOR GENE; GALLBLADDER DISEASE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; LIVER CELL; MALE; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; RAT; RAT STRAIN; RISK FACTOR; SHP GENE; STRAIN DIFFERENCE; STREPTOZOCIN DIABETES;

ANIMALS; BASE SEQUENCE; DIABETES MELLITUS, EXPERIMENTAL; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GLUCOSE; HEPATOCYTES; INSULIN; KINETICS; LIVER; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 1842527650     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.4.890     Document Type: Article

References (49)

1. Boland LL, Folsom AR, Rosamond WD: Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease: a prospective study. Ann Epidemiol 12:131-140, 2002
2. Ruhl CE, Everhart JE: Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 31:299-303, 2000
3. De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, De Luca C, Pinto G, Lisi D, Capocaccia L: Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 25:787-790, 1997
4. Andersen E, Hellstrom P, Hellstrom K: Cholesterol biosynthesis in nonketotic diabetics before and during insulin therapy. Diabetes Res Clin Pract 3:207-214, 1987
5. Bennion LJ, Grundy SM: Effects of diabetes mellitus on cholesterol metabolism in man. N Engl J Med 296:1365-1371, 1977
6. Lefrancois-Martinez AM, Martinez A, Antoine B, Raymondjean M, Kahn A: Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem 270:2640-2643, 1995
7. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Liepvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferre P, Foufelle F: ADD1/ SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19:3760-3768, 1999
8. Lou DQ, Tannour M, Selig L, Thomas D, Kahn A, Vasseur-Cognet M: Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response. J Biol Chem 274:28385-28394, 1999
9. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, Arnot D, Uyeda K: A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 98:9116-9121, 2001
10. Doiron B, Cuif MH, Chen R, Kahn A: Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway. J Biol Chem 271:5321-5324, 1996
11. Massillon D, Chen W, Barzilai N, Prus-Wertheimer D, Hawkins M, Liu R, Taub R, Rossetti L: Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats. J Biol Chem 273:228-234, 1998
12. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED: High glucose-induced transforming growth factor betal production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160-169, 1998
13. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, et al.: Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687-693, 1995
14. Seol W, Choi HS, Moore DD: Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol 9:72-85, 1995
15. Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, Edwards PA: Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem 275:10638-10647, 2000
16. Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, Fruchart JC, Dallongeville J, Hum DW, Kuipers F, Staels B: Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest 109:961-971, 2002
17. Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B: FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124:1926-1940, 2003
18. Wang H, Chen J, Hollister K, Sowers LC, Forman BM: Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3:543-553, 1999
19. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM: Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365-1368, 1999
20. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B: Identification of a nuclear receptor for bile acids. Science 284:1362-1365, 1999
21. Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, Creech KL, Moore LB, Wilson JG, Lewis MC, Jones SA, Willson TM: Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 43:2971-2974, 2000
22. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507-515, 2000
23. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA: A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526, 2000
24. Grober J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, Ono T, Besnard P: Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene: involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J Biol Chem 274:29749-29754, 1999
25. Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, Karpen SJ: The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121:140-147, 2001
26. Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ: Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276:28857-28865, 2001
27. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277:2908-2915, 2002
28. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731-744, 2000
29. Lambert G, Amar MJ, Guo G, Brewer HB Jr, Gonzalez FJ, Sinal CJ: The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem 278:2563-2570, 2003
30. Kast HR, Nguyen CM, Sinal CJ, Jones SA, Laffitte BA, Reue K, Gonzalez FJ, Willson TM, Edwards PA: Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol 15:1720-1728, 2001
31. Mak PA, Kast-Woelbern HR, Anisfeld AM, Edwards PA: Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors. J Lipid Res 43:2037-2041, 2002
32. Urizar NL, Dowhan DH, Moore DD: The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem 275:39313-39317, 2000
33. Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, Staels B: Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 125:544-555, 2003
34. Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B: Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol 17:259-272, 2003
35. van Waarde WM, Verkade HJ, Wolters H, Havinga R, Baller J, Bloks V, Muller M, Sauer PJ, Kuipers F: Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats. Gastroenterology 122:1842-1852, 2002
36. Torra IP, Tsibulsky V, Delaunay F, Saladin R, Laudet V, Fruchart JC, Kosykh V, Staels B: Circadian and glucocorticoid regulation of Reverbalpha expression in liver. Endocrinology 141:3799-3806, 2000
37. Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C: Peroxisome proliferator-activated receptor alpha (PPARalpha) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes. J Biol Chem 277:37254-37259, 2002
38. Decaux JF, Antoine B, Kahn A: Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. J Biol Chem 264:11584-11590, 1989
39. Twisk J, Hoekman MF, Lehmann EM, Meijer P, Mager WH, Princen HM: Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription. Hepatology 21:501-510, 1995
40. Peterson RG, Shaw WN, Neel M-A, Little LA, Eichberg J: Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR Journal 32:16-19, 1990
41. Nawano M, Oku A, Ueta K, Umebayashi I, Ishirahara T, Arakawa K, Saito A, Anai M, Kikuchi M, Asano T: Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab 278:E535-E543, 2000
42. Xu G, Pan L, Li H, Forman BM, Erickson SK, Shefer S, Bollioneni J, Batta AK, Christie J, Wang TH, Michel J, Yang S, Tsai R, Lai L, Shimada K, Tint GS, Salen G: Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. J Biol Chem 277:50491-50496, 2002
43. Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, Stoffel M: Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27:375-382, 2001
44. Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C: Repression of farnesoid X receptor during the acute phase response. J Biol Chem 278:8988-8995, 2003
45. Vaulont S, Vasseur-Cognet M, Kahn A: Glucose regulation of gene transcription. J Biol Chem 275:31555-31558, 2000
46. Dills WL Jr, Parsons PD, Westgate CL, Komplin NJ: Assay, purification, and properties of bovine liver D-xylulokinase. Protein Expr Purif 5:259-265, 1994
47. Liu YQ, Uyeda K: A mechanism for fatty acid inhibition of glucose utilization in liver: role of xylulose 5-P. J Biol Chem 271:8824-8830, 1996
48. Nishimura M, Uyeda K: Purification and characterization of a novel xylulose 5-phosphate-activated protein phosphatase catalyzing dephosphorylation of fructose-6-phosphate,2-kinase:fructose-2,6-bisphosphatase. J Biol Chem 270:26341-26346, 1995
49. Gustafson LA, Neeft M, Reijngoud DJ, Kuipers F, Sauerwein HP, Romijn JA, Herling AW, Burger HJ, Meijer AJ: Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes. Biochem J 358:665-671, 2001